Postsynaptic density protein: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: ==PSD-95== <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> This is a default text for your page '''Blair Matzker/sandbox 1'''. Click ab... |
No edit summary |
||
| Line 10: | Line 10: | ||
== Disease == | == Disease == | ||
There are more than 130 diseases are attributed to changes in the proteome of excitatory synapses. Given that PSD-95 belongs to the proteome of excitatory synapses, research has found that any mutations with PSD-95 caused complications not only for how quickly synapses transmitted neurotransmitters but its capability to conform to new stresses. Therefore, since PSD-95 is integral for synaptic stability, a decrease in PSD-95 has substantial neurological effects based on age and the area of the brain affected. | There are more than 130 diseases are attributed to changes in the proteome of excitatory synapses. Given that PSD-95 belongs to the proteome of excitatory synapses, research has found that any mutations with PSD-95 caused complications not only for how quickly synapses transmitted neurotransmitters but its capability to conform to new stresses. Therefore, since PSD-95 is integral for synaptic stability, a decrease in PSD-95 has substantial neurological effects based on age and the area of the brain affected. | ||
1. Media Prefrontal Cortex - Under normal circumstances, PSD-95 continues to increase from birth until peaking during adolescents. However, if the PSD-95 is decreased, it will affect the medial prefrontal cortex (mPFC) which is responsible for cognition, working memory, and sociability (Coley, 2019). Researchers found that the PSD-95 knockout mice lacked sociability and exhibited both learning and working memory deficiencies. The dysfunction of PSD-95 is believed to manifest to some degree in humans as either schizophrenia or as autism (Coley, 2019). It has also been linked to Alzheimer’s by a research study. | |||
2. Superior Temporal Sulcus - This research study focused on the superior temporal sulcus. The disease is mainly characterized by neuronal damage, neuronal death, and brain atrophy. The study found that in a group of post-mortem subjects; demented subjects had 50% less PSD-95 concentration than the control group (Perez-Nievas, 2013). This was compared to a group that had many of the same morphological signs as those with Alzheimer’s but suffered no adverse effects from it. This group had significantly more PSD-95 than a normal brain, perhaps to counter act the degrading aspects. | 1.Media Prefrontal Cortex - Under normal circumstances, PSD-95 continues to increase from birth until peaking during adolescents. However, if the PSD-95 is decreased, it will affect the medial prefrontal cortex (mPFC) which is responsible for cognition, working memory, and sociability (Coley, 2019). Researchers found that the PSD-95 knockout mice lacked sociability and exhibited both learning and working memory deficiencies. The dysfunction of PSD-95 is believed to manifest to some degree in humans as either schizophrenia or as autism (Coley, 2019). It has also been linked to Alzheimer’s by a research study. | ||
3. Corpus Striatum – A study of cocaine abuse using a mice study suggests that psychostimulants decrease the PSD-95 levels in both the dorsal and ventral portions of the striatum though the hippocampus and cortex were unaffected. While less than 2 injections made little change in PSD-95 levels, 3 to 10 injections resulted in substantial chronic PSD-95 loss; however, 11 or more injections showed no additional decreases (Yao et al., 2004). When studied months after the last injection, the deficits in PSD-95 remained, suggesting long-term neuronal effects of drug use. | |||
2.Superior Temporal Sulcus - This research study focused on the superior temporal sulcus. The disease is mainly characterized by neuronal damage, neuronal death, and brain atrophy. The study found that in a group of post-mortem subjects; demented subjects had 50% less PSD-95 concentration than the control group (Perez-Nievas, 2013). This was compared to a group that had many of the same morphological signs as those with Alzheimer’s but suffered no adverse effects from it. This group had significantly more PSD-95 than a normal brain, perhaps to counter act the degrading aspects. | |||
3.Corpus Striatum – A study of cocaine abuse using a mice study suggests that psychostimulants decrease the PSD-95 levels in both the dorsal and ventral portions of the striatum though the hippocampus and cortex were unaffected. While less than 2 injections made little change in PSD-95 levels, 3 to 10 injections resulted in substantial chronic PSD-95 loss; however, 11 or more injections showed no additional decreases (Yao et al., 2004). When studied months after the last injection, the deficits in PSD-95 remained, suggesting long-term neuronal effects of drug use. | |||
== Relevance == | == Relevance == | ||